KMDA today
$8.13+$0.03 (+0.37%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bullish
1 hourAscending Triangle
15 minStrong Bullish
5 minExpanding
Daily trend turns up above $8.09
Key levels
Resistance$8.96
Resistance$8.60
Support$8.09
Support$7.56
Latest news & SEC filings
EarningsKamada posts record results and raises 2026 guidance
EarningsKamada holds Q3 2026 earnings call
EarningsKamada quarterly profit tops view while revenue falls short
GuidanceKamada lifts FY2026 sales guidance to $205M-$208M from $200M-$205M
All KMDA news →About Kamada
Kamada is an Israeli biopharmaceutical company that develops, manufactures, and markets plasma-derived protein therapeutics. Its products treat rare and serious conditions, including specialty plasma-derived treatments and biosimilar candidates. The company sells directly in Israel and the United States and distributes its products in other international markets through partners.
Based on the company's 20-F filed Mar 11, 2026.
Nasdaq · Healthcare
KAMADA LTD (KMDA)
What Is the Price Target for KMDA?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is KMDA a Buy or Sell Right Now?
Thesis
- •Revenue growing 12.1% YoY with STABLE trend — consistent growth.
- •SEC filings signal active product innovation — 1 new product/expansion keywords detected in 10-K. R&D investment stable.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for KMDA.
Start Free Trial →Is KMDA Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, PEG
Fair Value
$14.68
38
Moat Score
NONE
6/9
Piotroski Score
N/A
Altman Z-Score
What Is Smart Money Doing with KMDA?
Insider Signal
NEUTRAL
0 buys / 3 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Tsur David | director | Sale | 175 | $1K | Sep 9, 2026 |
| Tsur David | director | Sale | 162,760 | $1.3M | Sep 8, 2026 |
| Tsur David | director | Sale | 14,238 | $118K | Sep 7, 2026 |
| Brenner Yael | officer | Buy | 10,000 | $63K | Aug 26, 2026 |
| Brenner Yael | officer | Sale | 2,776 | $24K | Aug 26, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →KMDA Growth Story
Revenue YoY
12.1%
3yr Revenue CAGR
11.7%
EPS Growth YoY
40%
FCF Growth YoY
N/A%
Revenue Trend
STABLE
Dark Pool Trades for KMDA
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for KMDA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:43:45 | $8.13 | 1,000 | $$8K | BUY |
| 19:41:39 | $8.10 | 2,359 | $$19K | BUY |
| 18:10:11 | $8.07 | 1,000 | $$8K | SELL |
| 16:12:34 | $8.04 | 1,700 | $$14K | SELL |
| 15:36:31 | $8.08 | 1,090 | $$9K | BUY |
5 dark pool trades shown · $$58K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for KMDA
PREVIEWSEPT Investing provides real-time options flow tracking for KMDA, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| PUT | $5 | May 21 | 191 | $$30 | 2 | SWEEP |
1 options trades shown · 0% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for KAMADA LTD (KMDA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (4 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →KMDA — frequently asked questions
What is KMDA stock price today?
KAMADA LTD (KMDA) is at $8.13, up 0.37% (+$0.03) at the Nov 11, 2026 close.
Why is KMDA stock moving today?
Latest KMDA news — Nov 9, 2026: Kamada posts record results and raises 2026 guidance · Nov 9, 2026: Kamada holds Q3 2026 earnings call
Why did KMDA stock move on Nov 9, 2026?
Kamada shares rose 4.90% to close at $7.71 after the company reported its strongest financial results to date and raised its fiscal 2026 sales guidance to $205M-$208M from $200M-$205M, with the new midpoint above the $202.96M analyst estimate. Quarterly earnings per share of $0.14 topped the $0.13 consensus, though revenue of $52.034M fell short of the $52.506M forecast.
What do analysts rate KMDA?
Analyst ratings for KMDA: 3 Buy, 0 Hold, 0 Sell — consensus Strong Buy.
Did KMDA beat earnings?
KMDA last reported on Nov 9, 2026: EPS $0.14 vs $0.13 expected — a beat of 7.7%.
What is KMDA's P/E ratio?
KMDA trades at a P/E of 22.1 vs a Healthcare average of 17.3.
Does KMDA pay a dividend?
Yes. KMDA's dividend yield is 3.07%.
What are KMDA support and resistance levels?
Support: $8.09, $7.56, $6.77. Resistance: $8.60, $8.96, $9.35.
What are insiders doing with KMDA?
Insider activity: NEUTRAL, 0 buys and 3 sells in the last 90 days.
What is the latest news on KMDA?
Nov 9, 2026: Kamada posts record results and raises 2026 guidance · Nov 9, 2026: Kamada holds Q3 2026 earnings call · Nov 9, 2026: Kamada quarterly profit tops view while revenue falls short